Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
11/2001
11/29/2001US20010046696 Sugar compounds
11/29/2001US20010046692 Derived from Pseudomonas jessenii
11/29/2001US20010046691 Enhanced production of lipids containing polyenoic fatty acid by very high density cultures of eukaryotic microbes in fermentors
11/29/2001US20010046532 From a culture medium of whole milk, water, and a food grade gum such as agar, xanthan, alginate, guar, carrageenan, cellulose gels; body, texture and flavor that compares favorably with full fat cheddar cheese
11/29/2001US20010046524 Administering to the patient a formulation comprising an extract of Eucommia ulmoides (plant extract) or an extract of botanical equivalent of Eucommia extract or acomponent to modulalte steroid-mediated physiological condition
11/29/2001US20010046485 Isolated and purified fungus, Hirsutella minnestonesis
11/29/2001US20010046484 Adding viable bacillus to feed
11/29/2001DE10102823A1 Verfahren zur fermentativen Herstellung von L-Threonin A process for the fermentative preparation of L-threonine
11/29/2001DE10025033A1 Verfahren zur elektrischen Energiegewinnung mit Hilfe einer Brennstoffzelle Method for the electrical energy using a fuel cell
11/29/2001CA2808215A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
11/29/2001CA2429199A1 Drug metabolizing enzymes
11/29/2001CA2410520A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome)
11/29/2001CA2410350A1 Use of lactobacillus casei in immunostimulatory compounds
11/29/2001CA2410101A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/29/2001CA2410096A1 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001CA2410094A1 Compositions and methods for modulating tumor specific expression
11/29/2001CA2410083A1 Mammalian receptor proteins; related reagents and methods
11/29/2001CA2410082A1 Dnax toll-like receptor 7 (dtlr7) protein, related reagents and methods
11/29/2001CA2410081A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/29/2001CA2409974A1 Lactobacillus reuteri glucosyltransferase
11/29/2001CA2409299A1 Compositions and methods for the therapy and diagnosis of breast cancer
11/29/2001CA2409137A1 Method for microbial production of difructose anhydride iii, micro-organism used therefor and enzyme with inulase ii activity and dna sequences coding therefor
11/29/2001CA2408739A1 Novel proteins and nucleic acids encoding same, diagnostic and therapeutic uses
11/29/2001CA2408387A1 A ligand for enhancing oral and cns delivery of biological agents
11/29/2001CA2408315A1 Aminoacyl trna synthetases
11/29/2001CA2408302A1 Long wavelength engineered fluorescent proteins
11/29/2001CA2408141A1 Neurotransmitter transporters
11/29/2001CA2408140A1 G-protein coupled receptors
11/29/2001CA2408022A1 Pt32 sperm protein, sperm c-yes, oocyte cytoplasmic c-yes, and uses thereof
11/29/2001CA2407872A1 Receptor-based interaction trap
11/28/2001EP1158052A1 Beta-primeverosidase gene
11/28/2001EP1158051A1 Process for producing astaxanthin
11/28/2001EP1158050A1 Human cysteinyl leukotriene receptor (CysLT2)
11/28/2001EP1158048A1 Photoprotein derived from Okinawan squid and gene encoding the photoprotein
11/28/2001EP1158043A1 Process for producing l-lysine
11/28/2001EP1158002A1 Human G-protein coupled receptor
11/28/2001EP1157118A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
11/28/2001EP1157117A1 Polypeptides having galactose oxidase activity and nucleic acids encoding same
11/28/2001EP1157116A1 PHENOL-INDUCED PROTEINS OF $i(THAUERA AROMATICA)
11/28/2001EP1157109A2 14273 receptor, a g-protein coupled receptor
11/28/2001EP1157104A2 Pyk2 binding proteins
11/28/2001EP1157103A2 Production of helper dependent adenovirus vectors based on use of endonucleases
11/28/2001EP1157095A1 Fungal cells with inactivated dna mismatch repair system
11/28/2001EP1157094A2 Method for the purification, recovery, and sporulation of cysts and oocysts
11/28/2001EP1156819A1 Methods and compositions for modulating fertility
11/28/2001EP0924993B1 Dehydrated food containing lactic acid bacteria
11/28/2001EP0845032B1 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
11/28/2001EP0750672B1 Dna sequences for matrix metalloproteases, their production and use
11/28/2001CN1324409A Method of producing gamma-decalactone
11/28/2001CN1324408A Nucleic acid molecules from rice and their use for the prodn. of modified starch
11/28/2001CN1324407A Plant-optimized polynucleotides encoding approximately 15 KDa and approximately 45 KDa pesticidal proteins
11/28/2001CN1324405A Novel G protein-coupled receptor proteins, DNAS thereof and ligands to the same
11/28/2001CN1324403A PRV-1 gene and the use thereof
11/28/2001CN1324402A Constructing and screening a DNA library of interest in filamentous fungal cells
11/27/2001US6323396 Agrobacterium-mediated transformation of plants
11/27/2001US6323328 Human citrate synthase homolog
11/27/2001US6323322 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
11/27/2001US6323178 Beta-lipotropin methods
11/27/2001US6323026 Mutations in the KCNE1 gene encoding human mink which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene
11/27/2001US6323025 In vitro cell culture in media containing beta-alanyl-taurine or carbobenzoxy beta-alanyl-taurine
11/27/2001US6323021 Mutant strain of penicillium citrinum and use thereof for preparation of compactin
11/27/2001US6323015 Sucrose phosphate synthase
11/27/2001US6323010 Providing substrates which comprise 2-hydroxybutyric acid in biological system which is genetically engineered to express one or more enzymes selected from the group consisting of polyhydroxyalkanoate synthase, acyl-coa transferase, etc.
11/27/2001US6323002 Methods for modifying the production of a polypeptide
11/27/2001US6323000 To identify compounds that interact with it
11/27/2001US6322995 Recombinant gram positive bacterium used for producing riboflavin
11/27/2001US6322994 Storing microorganism samples; dispense liquid samples into separate wells, insert container into freezing apparatus, freeze dry samples
11/27/2001US6322991 High-throughput screens for enzyme inhibitors
11/27/2001US6322990 Methods of identifying agents that block the interaction of a BAP protein with a signaling partner
11/27/2001US6322982 Modulation of drug resistance via ubiquitin carboxy-terminal hydrolase
11/27/2001US6322809 Containing one or more bacteria entrapped in liposome
11/27/2001US6322795 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses
11/27/2001CA2240392C Multimer forms of interleukin-16 (il-16), process for the preparation and use thereof
11/27/2001CA2083286C Recombinant fibrinogenases, preparation and use thereof
11/27/2001CA2074837C Methods of producing hybrid g protein-coupled receptors
11/27/2001CA2063511C Method for producing human serum albumin
11/27/2001CA1341322C Interleukin-1 inhibitors
11/22/2001WO2001088165A1 Nucleotide sequences coding for signal transduction components involved in plant pathogen defence
11/22/2001WO2001088163A1 Method for producing recombinant expansins
11/22/2001WO2001088161A1 Vector for analysing replication mechanism of rna virus and use thereof
11/22/2001WO2001088148A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/22/2001WO2001088145A1 Recombinant microorganism expressing polyhydroxyalkanoate biosynthesis enzyme and intracellular pha depolymerase
11/22/2001WO2001088143A1 Process for producing protein with reduction of acidic sugar chain and glycoprotein produced thereby
11/22/2001WO2001088138A1 Humanised antibodies to the epidermal growth factor receptor
11/22/2001WO2001088137A2 Human myd88 adapter-like protein and functional fragments thereof
11/22/2001WO2001088136A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/22/2001WO2001088132A2 Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods
11/22/2001WO2001088130A1 Molecular cloning and identification of a human leukotriene-like receptor ltxr
11/22/2001WO2001088129A1 Anti-angiogenic polypeptides
11/22/2001WO2001088128A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/22/2001WO2001088125A1 MUTATION IN THE β2 NICOTINIC ACETYLCHOLINE RECEPTOR SUBUNIT ASSOCIATED WITH NOCTURNAL FRONTAL LOBE EPILEPSY
11/22/2001WO2001088121A1 Vector constructs
11/22/2001WO2001088119A1 Novel g protein-coupled receptor protein and dna thereof
11/22/2001WO2001088118A1 Novel motor proteins and methods for their use
11/22/2001WO2001088117A2 In vitro fucosylation recombinant glycopeptides
11/22/2001WO2001088108A1 Neuronal serine-threonine protein kinase
11/22/2001WO2001088106A2 Novel deoxyribonucleside kinase enzyme multi-substrate variants
11/22/2001WO2001088095A1 Microorganisms for treatment or prevention of obesity and diabetes mellitus, and pharmaceutical composition containing the same
11/22/2001WO2001088094A1 A recombinant yeast for lignocellulose raw materials
11/22/2001WO2001088093A1 Complex culture, process for producing complex culture, pre-culture, process for producing pre-culture and process for producing microbial preparations